Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes

Comparison of Technosphere® Insulin Versus Technosphere Powder (Placebo) in Insulin-Naive Subjects With Type 2 Diabetes Mellitus

NCT01451398 ·Status: COMPLETED ·Phase: PHASE3

Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease

NCT00642616 ·Status: TERMINATED ·Phase: PHASE3

Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma

NCT00332826 ·Status: TERMINATED ·Phase: PHASE3

Healthy Normal Volunteers Looking at Exposure and Effects of Multiple Doses of Technosphere® Insulin (TI) Using the Gen2C Inhaler

NCT01490762 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial Evaluating the Efficacy and Safety of Technosphere® Inhalation Insulin (TI) Inhalation Powder Using the Gen2 Inhaler

NCT01196104 ·Status: TERMINATED ·Phase: PHASE3

A Study to Evaluate Insulin in the Blood After Inhalation of a Dry Powder Insulin Formulation (Called Technosphere®/Insulin) in Non-diabetic Patients With & Without Chronic Obstructive Pulmonary Disease (COPD)

NCT01021891 ·Status: COMPLETED ·Phase: PHASE1

Clamp Study Comparing Inhalation of Technosphere®/Insulin in Smokers and Non-Smokers With Type 2 Diabetes

NCT00934414 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial Evaluating Technosphere® Insulin Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Over a 24-week Treatment Period

NCT01445951 ·Status: COMPLETED ·Phase: PHASE3

18-Week, Randomized, Double-blind, Placebo Controlled, Forced Titration Study of Patients With Type 2 Diabetes

NCT00511732 ·Status: COMPLETED ·Phase: PHASE2

A Trial to Determine How Long Insulin and FDKP (the Molecule That Forms Technosphere Particles) Stays in the Lungs of Healthy Individuals After Inhalation of Technosphere® Insulin (TI) Powder Using Bronchoalveolar Lavage (BAL)

NCT00757367 ·Status: COMPLETED ·Phase: PHASE1

An Open-label, Multi-center, International, Three-year, Safety and Tolerability 'Follow on' Trial

NCT00754624 ·Status: COMPLETED ·Phase: PHASE2

To Compare the Effect of Inhaled Insulin With Subcutaneously Injected Insulin in Subjects With Type 2 Diabetes Mellitus.

NCT00419302 ·Status: COMPLETED ·Phase: PHASE2

Bioavailability of Technosphere® Insulin Versus Subcutaneous Regular Human Insulin in Type 2 Diabetes

NCT00511719 ·Status: COMPLETED ·Phase: PHASE2

Comparison of Technosphere Insulin Inhalation Powder & Subcutaneous Rapid-Acting Analog in Subjects With Type 1 Diabetes

NCT01544881 ·Status: COMPLETED ·Phase: PHASE1

Single Site, Single Subject, Treatment IND With Mannkind Corporation's Technosphere Inhalation System

NCT01459133 ·Status: WITHDRAWN ·Phase: NA

Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD)

NCT00472953 ·Status: TERMINATED ·Phase: PHASE3

Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 1 Diabetes Mellitus.

NCT00424437 ·Status: COMPLETED ·Phase: PHASE3

Patient Transitioning From Exubera® Inhalation Powder to Technosphere® Insulin Inhalation Powder

NCT01798914 ·Status: NO_LONGER_AVAILABLE

A 2-Month Safety Follow-Up Trial

NCT00741429 ·Status: COMPLETED

A Study Designed to Determine if the Pharmacokinetic Disposition of Inhaled Insulin Exposure is the Same for Asthmatics and Non-asthmatics

NCT00673621 ·Status: COMPLETED ·Phase: PHASE1

A Study Designed to Compare 2 Dose Strengths of TI Inhalation Powder in Adults With Type 1 Diabetes Mellitus and to Compare One of Those Formulations (30Units) With an Injection of Insulin Lispro

NCT00662857 ·Status: COMPLETED ·Phase: PHASE2

Effects of URI on Diabetic Subjects Utilizing Technosphere Insulin After a Meal Challenge

NCT00642681 ·Status: COMPLETED

Study Comparing Prandial Insulin Aspart vs. Technosphere Insulin in Patients With Type 1 Diabetes on Multiple Daily Injections: Investigator-Initiated A Real-life Pilot Study-STAT Study

NCT03143816 ·Status: COMPLETED ·Phase: PHASE4

Pharmacokinetic Study in Healthy Volunteers

NCT01365117 ·Status: COMPLETED ·Phase: PHASE1

Investigating the Safety and Effectiveness of Insulin Degludec in a Real World Population With Type 1 and 2 Diabetes Mellitus

NCT02392117 ·Status: COMPLETED